According to the report published by Visiongain, the Brachytherapy market is projected at 514,2 million USD by 2020. The prediction era for 2020-2030 should include a CAGR of 4.8%.
The occurrence and death of cancer rely on a variety of variables, including era, socio-economic position, and geographical situation. External beam radiotherapy or brachytherapy are most common cancer medicines. Brachytherapy is progressively used in disease therapy, as a radiotherapy with electricity from radionuclides straight introduced into the body. For cervical and skin cancers, this has been the normal therapy for over 100 years and an significant aspect of other malignancies such as the headache, hair, heart and pussy diseases. This is also an significant treatment guideline. Brachytherapy can immediately give ablative radiation dose over a short time to the tissue region with the benefit of quick decrease in exposure and subsequently the spare of the neighboring organ compared to external beam radiation therapy. As a consequence, patients can finish the therapy sooner than standard radiation therapy, and the risk of another disease is smaller. The use of brachytherapy as radical or palliative therapy has risen and the distribution of dose-powered and high dose afterloading devices has progressed; further improvement of the performance was achieved with the use of new 3D/4D scheduling technologies.
In comparison with EBRT alone, BT’s effectiveness is due to the capacity of radioactive implants, which contribute to enhanced local command, in so far as the bone is clinically delimitable and available, to give a greater focused radiation load to cells more exactly. The good tissues are also prevented. at the same moment. BT is invasive and needs to be inserted under sedation or anesthesia in comparison to EBRT. Sometimes the doctor (especially when laparotomy or craniotomy) who takes part in these processes is needed for inserting an applicator or for tissue resection to be required before delivery by the applicator.
Brachytherapy is an interior radiation treatment, which is used either permanently (sometimes referred to as’ implantation seeds’) or temporarily by catheters, where the radioactive triggers are positioned. Radioactive materials are put inside the organism (plants or catheters) and positioned to manage the disease most efficiently. When continuous brachytherapy is used, the radioactive’ seed’ is kept inside the flesh. As seed radiation declines over moment, it measures how soon they are radioactive in the flesh. The half-life of the radioactive isotope is used. Temporary brachytherapy usually involves either an inpatient (LDR) procedure with the patient being hospitalized for several days, while radioactive sources treat the disease; or an outpatient treatment (HDR), where the patient typically undergoes multiple radiation therapies within a short period of time. (HDR). Temporary brachytherapy normally takes place in a hospital. LDR (pulsed dose-rate) technologies are substituted in many centres around the world.
Why you should buy Brachytherapy Market Forecast 2020-2030: Forecasts and Analysis by Type (High Dose Rate, Low Dose Rate), By Application (Prostate, Breast, Gynecological Cancer) and Geography, with Profiles of Leading Companies
What is the future of the Brachytherapy market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information –
– View Brachytherapy market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Brachytherapy revenue forecast
– Brachytherapy connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Brachytherapy market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Brachytherapy sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Brachytherapy industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Brachytherapy submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– Application submarket forecast 2020-2030
– Dosage submarket forecast 2020-2030
– Learn about the market prospects for the leading Brachytherapy market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Brachytherapy revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Type Revenue Forecast 2020-2030
– High Dose Rate (HDR) Market Forecast, 2020-2030
– Low Dose Rate (LDR) Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030
– Application Revenue Forecast 2020-2030
– Prostate Cancer Market Forecast, 2020-2030
– Cervical Cancer Market Forecast, 2020-2030
– Breast Cancer Market Forecast, 2020-2030
– Skin Cancer Market Forecast, 2020-2030
– Esophageal Cancer Market Forecast, 2020-2030
– Gynecologic Cancers Market Forecast, 2020-2030
– Anal/Rectal Tumors Market Forecast, 2020-2030
– Head And Neck Cancers Market Forecast, 2020-2030
– Dosage Revenue Forecast 2020-2030
– Low-dose-rate (LDR) Market Forecast, 2020-2030
– Pulsed-dose-rate (PDR) Market Forecast, 2020-2030
– Medium-dose-rate (MDR) Market Forecast, 2020-2030
– High-dose-rate (HDR) Market Forecast, 2020-2030
– Ultra LDR Market Forecast, 2020-2030
– Other Dosage Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Brachytherapy markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Brachytherapy companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Brachytherapy revenue forecast 2020-2030
– US Brachytherapy revenue forecast 2020-2030
– Canada Brachytherapy revenue forecast 2020-2030
– Mexico Brachytherapy revenue forecast 2020-2030
– North America Brachytherapy by Type revenue forecast 2020-2030
– North America Brachytherapy by Application revenue forecast 2020-2030
– North America Brachytherapy by Dosage revenue forecast 2020-2030
– Asia Pacific Brachytherapy revenue forecast 2020-2030
– China Brachytherapy revenue forecast 2020-2030
– Japan Brachytherapy revenue forecast 2020-2030
– India Brachytherapy revenue forecast 2020-2030
– Australia Brachytherapy revenue forecast 2020-2030
– Rest of Asia Pacific Brachytherapy revenue forecast 2020-2030
– Asia Pacific Brachytherapy by Type revenue forecast 2020-2030
– Asia Pacific Brachytherapy by Application revenue forecast 2020-2030
– Asia Pacific Brachytherapy by Dosage revenue forecast 2020-2030
– European Brachytherapy revenue forecast 2020-2030
– Germany Brachytherapy revenue forecast 2020-2030
– UK Brachytherapy revenue forecast 2020-2030
– France Brachytherapy revenue forecast 2020-2030
– Italy Brachytherapy revenue forecast 2020-2030
– Spain Brachytherapy revenue forecast 2020-2030
– Rest of Europe Brachytherapy revenue forecast 2020-2030
– European Brachytherapy by Type revenue forecast 2020-2030
– European Brachytherapy by Application revenue forecast 2020-2030
– European Brachytherapy by Dosage revenue forecast 2020-2030
– Rest of World Brachytherapy revenue forecast 2020-2030
– Rest of World Brachytherapy by Type revenue forecast 2020-2030
– Rest of World Brachytherapy by Application revenue forecast 2020-2030
– Rest of World Brachytherapy by Dosage revenue forecast 2020-2030
– Explore the factors affecting Brachytherapy product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Brachytherapy industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Brachytherapy companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Brachytherapy Market
Sun Nuclear Corporation
Huiheng Medical
Civco Medical Solutions
Varian Medical Systems, Inc.
Icad, Inc.
C. R. Bard, Inc.
Theragenics
Isoray Medical, Inc.
Bard Medical Division
Best Medical International, Inc.
Discover Information found nowhere else in this independent assessment of the Brachytherapy market
The Brachytherapy Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By Dosage and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Brachytherapy sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Brachytherapy Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By Dosage and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Brachytherapy market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Brachytherapy sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Brachytherapy Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By Dosage and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Brachytherapy sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Brachytherapy Market Definition
1.2 Global Brachytherapy Market Overview
1.3 Global Brachytherapy Market Segmentation
1.4 Research Scope of Brachytherapy in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Brachytherapy Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 Brachytherapy is progressively used in disease therapy, as a radiotherapy with electricity from radionuclides straight introduced into the body
2.4.2 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness
2.4.3 Growing Use of Particle Therapy for Cancer Treatment
2.4.4 Affordability and Accessibility of Treatment
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Brachytherapy Market Analysis
3.1 PEST Analysis of the Brachytherapy Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Brachytherapy Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Brachytherapy: Global Market Analysis by Segments
4.1 Global Brachytherapy Market Forecast, by Type 2020-2030
4.1.1 Type Overview
4.1.2 High Dose Rate (HDR) Market Forecast, 2020-2030
4.1.3 Low Dose Rate (LDR) Market Forecast, 2020-2030
4.1.4 Other Type Market Forecast, 2020-2030
4.2 Global Brachytherapy Market Forecast, by Application 2020-2030
4.2.1 Application Overview
4.2.2 Prostate Cancer Market Forecast, 2020-2030
4.2.3 Cervical Cancer Market Forecast, 2020-2030
4.2.4 Breast Cancer Market Forecast, 2020-2030
4.2.5 Skin Cancer Market Forecast, 2020-2030
4.2.6 Esophageal Cancer Market Forecast, 2020-2030
4.2.7 Gynecologic Cancers Market Forecast, 2020-2030
4.2.7 Anal/Rectal Tumors Market Forecast, 2020-2030
4.2.7 Head And Neck Cancers Market Forecast, 2020-2030
4.3 Global Brachytherapy Market Forecast, by Dosage 2020-2030
4.3.1 Dosage Overview
4.3.2 Low-dose-rate (LDR) Market Forecast, 2020-2030
4.3.3 Pulsed-dose-rate (PDR) Market Forecast, 2020-2030
4.3.4 Medium-dose-rate (MDR) Market Forecast, 2020-2030
4.3.5 High-dose-rate (HDR) Market Forecast, 2020-2030
4.3.6 Ultra LDR Market Forecast, 2020-2030
4.3.7 Other Dosage Market Forecast, 2020-2030
5. Leading Regions in Brachytherapy Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Brachytherapy Market Forecast, 2020-2030
5.2.1 North America Brachytherapy Submarket, By Type Forecast 2020-2030
5.2.2 North America Brachytherapy Submarket, By Application Forecast 2020-2030
5.2.3 North America Brachytherapy Submarket, By Dosage Forecast 2020-2030
5.2.4 North America Brachytherapy Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Brachytherapy Market, Forecast 2020-2030
5.2.4.2 Canada Brachytherapy Market, Forecast 2020-2030
5.2.4.3 Mexico Brachytherapy Market, Forecast 2020-2030
5.3 Europe Brachytherapy Market Forecast, 2020-2030
5.3.1 Europe Brachytherapy Submarket, By Type Forecast 2020-2030
5.3.2 Europe Brachytherapy Submarket, By Application Forecast 2020-2030
5.3.3 Europe Brachytherapy Submarket, By Dosage Forecast 2020-2030
5.3.4 Europe Brachytherapy Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Brachytherapy Market, Forecast 2020-2030
5.3.4.2 Germany Brachytherapy Market, Forecast 2020-2030
5.3.4.3 France Brachytherapy Market, Forecast 2020-2030
5.3.4.4 Italy Brachytherapy Market, Forecast 2020-2030
5.3.4.5 Spain Brachytherapy Market, Forecast 2020-2030
5.3.4.6 The Netherlands Brachytherapy Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Brachytherapy Market, Forecast 2020-2030
5.4 Asia-Pacific Brachytherapy Market Forecast, 2020-2030
5.4.1 Asia-Pacific Brachytherapy Submarket, By Type Forecast 2020-2030
5.4.2 Asia-Pacific Brachytherapy Submarket, By Application Forecast 2020-2030
5.4.3 Asia-Pacific Brachytherapy Submarket, By Dosage Forecast 2020-2030
5.4.4 Asia-Pacific Brachytherapy Submarket, By Country Forecast 2020-2030
5.4.4.1 China Brachytherapy Market, Forecast 2020-2030
5.4.4.2 India Brachytherapy Market, Forecast 2020-2030
5.4.4.3 Japan Brachytherapy Market, Forecast 2020-2030
5.4.4.4 Korea Brachytherapy Market, Forecast 2020-2030
5.4.4.5 Indonesia Brachytherapy Market, Forecast 2020-2030
5.4.4.6 Australia Brachytherapy Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Brachytherapy Market, Forecast 2020-2030
5.5 Rest of World Brachytherapy Market Forecast, 2020-2030
5.5.1 Rest of World Brachytherapy Submarket, By Type Forecast 2020-2030
5.5.2 Rest of World Brachytherapy Submarket, By Application Forecast 2020-2030
5.5.3 Rest of World Brachytherapy Submarket, By Dosage Forecast 2020-2030
6. Leading Companies in The Brachytherapy Market
6.1 Sun Nuclear Corporation
6.1.1 Sun Nuclear Corporation Overview
6.1.2 Analysis of Sun Nuclear Corporation Products and Services
6.1.3 Sun Nuclear Corporation Primary Market Competitors 2019
6.1.4 Sun Nuclear Corporation Key Developments
6.2 Huiheng Medical
6.2.1 Huiheng Medical Company Overview
6.2.2 Analysis of Huiheng Medical Products and Services
6.2.3 Huiheng Medical Primary Market Competitors 2019
6.2.4 Huiheng Medical Key Developments
6.3 Civco Medical Solutions
6.3.1 Civco Medical Solutions Company Overview
6.3.2 Analysis of Civco Medical Solutions Products and Services
6.3.3 Civco Medical Solutions Primary Market Competitors 2019
6.3.4 Civco Medical Solutions Key Developments
6.4 Varian Medical Systems, Inc.
6.4.1 Varian Medical Systems, Inc. Company Overview
6.4.2 Analysis of Varian Medical Systems, Inc. Products and Services
6.4.3 Varian Medical Systems, Inc. Primary Market Competitors 2019
6.4.4 Varian Medical Systems, Inc. Key Developments
6.5 Icad, Inc.
6.5.1 Icad, Inc. Company Overview
6.5.2 Analysis of Icad, Inc. Products and Services
6.5.3 Icad, Inc. Primary Market Competitors 2019
6.5.4 Icad, Inc. Key Developments
6.6 C. R. Bard, Inc.
6.6.1 C. R. Bard, Inc. Company Overview
6.6.2 Analysis of C. R. Bard, Inc. Products and Services
6.6.3 C. R. Bard, Inc. Primary Market Competitors 2019
6.6.4 C. R. Bard, Inc. Key Developments
6.7 Theragenics
6.7.1 Theragenics Company Overview
6.7.2 Analysis of Theragenics Products and Services
6.7.3 Theragenics Primary Market Competitors 2019
6.7.4 Theragenics Key Developments
6.8 Isoray Medical, Inc.
6.8.1 Isoray Medical, Inc. Company Overview
6.8.2 Analysis of Isoray Medical, Inc. Products and Services
6.8.3 Isoray Medical, Inc. Primary Market Competitors 2019
6.8.4 Isoray Medical, Inc. Key Developments
6.9 Bard Medical Division
6.9.1 Bard Medical Division Company Overview
6.9.2 Analysis of Bard Medical Division Products and Services
6.9.3 Bard Medical Division Primary Market Competitors 2019
6.9.4 Bard Medical Division Key Developments
6.10 Best Medical International, Inc.
6.10.1 Best Medical International, Inc. Company Overview
6.10.2 Analysis of Best Medical International, Inc. Products and Services
6.10.3 Best Medical International, Inc. Primary Market Competitors 2019
6.10.4 Best Medical International, Inc. Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Brachytherapy Market Segmentation
Figure 2.1 Brachytherapy Value Chain Analysis
Figure 3.1 Brachytherapy Supply-Demand Analysis
Figure 4.1 Global Brachytherapy Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Brachytherapy Market Forecast 2020-2030
Figure 4.3 Global Brachytherapy Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Brachytherapy Market By Type Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Brachytherapy by Submarket By Type Forecast 2020-2030 ($ million)
Figure 4.20 Global Brachytherapy Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Brachytherapy Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Brachytherapy Market, By Dosage System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Brachytherapy Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Brachytherapy Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Brachytherapy Market, by 2020-2030
Figure 5.3 Leading Country/Regional Brachytherapy Market Share, by 2020
Figure 5.4 Leading Country/Regional Brachytherapy Market Share, by 2025
Figure 5.5 Leading Country/Regional Brachytherapy Market Share, by 2030
Figure 5.6 Europe Brachytherapy Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Brachytherapy Market, by Forecast 2020-2030
Figure 5.8 Europe Brachytherapy Submarket, By Type Forecast 2020-2030
Figure 5.9 Europe Brachytherapy Submarket , By Application Forecast 2020-2030
Figure 5.10 Europe Brachytherapy Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Brachytherapy Submarket , By Dosage 2020-2030 ($billion, AGR%)
Figure 5.10 North America Brachytherapy Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Brachytherapy Market, by Forecast 2020-2030
Figure 5.12 North America Brachytherapy Submarket, By Type Forecast 2020-2030
Figure 5.13 North America Brachytherapy Submarket , By Application Forecast 2020-2030
Figure 5.14 North America Brachytherapy Submarket , By Dosage Forecast 2020-2030
Figure 5.13 North America Brachytherapy Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Brachytherapy Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Brachytherapy Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Brachytherapy Submarket, By Type Forecast 2020-2030
Figure 5.17 Asia-Pacific Brachytherapy Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Brachytherapy Submarket , By Dosage Forecast 2020-2030
Figure 5.18 Rest of World Brachytherapy Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Brachytherapy Market, by Forecast 2020-2030
Figure 5.20 Rest of World Brachytherapy Submarket, By Type Forecast 2020-2030
Figure 5.21 Rest of World Brachytherapy Submarket , By Application Forecast 2020-2030
Figure 5.21 Rest of World Brachytherapy Submarket , By Dosage Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Huiheng Medical Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Civco Medical Solutions Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Varian Medical Systems, Inc. Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Varian Medical Systems, Inc. Revenue % Share, by Dosage Segment, 2019
Figure 6.8 Varian Medical Systems, Inc. Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Varian Medical Systems, Inc. Revenue % Share, by Business Segment, 2019
Figure 6.10 Icad, Inc. Revenue % Share, by Geographic Segment, 2019
Figure 6.11 C. R. Bard, Inc. Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Theragenics Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Theragenics Revenue % Share, by Regional Segment, 2019
Figure 6.14 Isoray Medical, Inc. Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Isoray Medical, Inc. Revenue % Share, by Regional Segment, 2019
Figure 6.16 Isoray Medical, Inc. Revenue % Share, by Business Segment, 2019
Figure 6.17 Bard Medical Division Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Best Medical International, Inc. Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Best Medical International, Inc. Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Best Medical International, Inc. Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Brachytherapy Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Brachytherapy Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Brachytherapy Submarket, By Dosage Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Brachytherapy Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Brachytherapy Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Brachytherapy Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Brachytherapy Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Brachytherapy Market Submarket, By Dosage Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Brachytherapy Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Brachytherapy Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Brachytherapy Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Brachytherapy Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Brachytherapy Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Brachytherapy Market Submarket, By Dosage Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Brachytherapy Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Brachytherapy Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Huiheng Medical Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Huiheng Medical Products and Services (Product/Service, Segment)
Table 6.8 Huiheng Medical Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Huiheng Medical Total Company Recent Development 2015-2019
Table 6.10 Civco Medical Solutions Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Civco Medical Solutions Products and Services (Product/Service, Segment)
Table 6.12 Civco Medical Solutions Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Civco Medical Solutions Total Company Recent Development 2015-2019
Table 6.14 Varian Medical Systems, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Varian Medical Systems, Inc. Products and Services (Product/Service, Segment)
Table 6.16 Varian Medical Systems, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Varian Medical Systems, Inc. Total Company Recent Development 2015-2019
Table 6.18 Icad, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Icad, Inc. Products and Services (Product/Service, Segment)
Table 6.20 Icad, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Icad, Inc. Total Company Recent Development 2015-2019
Table 6.22 C. R. Bard, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 C. R. Bard, Inc. Products and Services (Product/Service, Segment)
Table 6.24 C. R. Bard, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 C. R. Bard, Inc. Total Company Recent Development 2015-2019
Table 6.26 Theragenics Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Theragenics Products and Services (Product/Service, Segment)
Table 6.28 Theragenics Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Theragenics Total Company Recent Development 2015-2019
Table 6.30 Isoray Medical, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Isoray Medical, Inc. Products and Services (Product/Service, Segment)
Table 6.32 Isoray Medical, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Isoray Medical, Inc. Total Company Recent Development 2015-2019
Table 6.34 Bard Medical Division Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Bard Medical Division Products and Services (Product/Service, Segment)
Table 6.36 Bard Medical Division Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Bard Medical Division Total Company Recent Development 2015-2019
Table 6.38 Best Medical International, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Best Medical International, Inc. Products and Services (Product/Service, Segment)
Table 6.40 Best Medical International, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Best Medical International, Inc. Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
